A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Name: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
Published: 2022
License: Public Domain

M.D. Anderson Cancer Center · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

microsatellite high cancers, peritoneal mesothelioma, extrapulmonary high grade, neuroendocrine carcinomas, cervical carcinoma, hodgkin's lymphoma, pleural mesothelioma, small cell lung cancer, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Related documents